Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech’s nasal vaccine
New Delhi: An expert panel of India’s drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine...